SARA BUCKHORN: Open Payments
NPI 1790314326 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 18 payments from 11 companies in 2025. Trend: 2023 $789 · 2024 $567 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $81 |
| ABBVIE INC. | 2 | $70 |
| Janssen Biotech, Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| EMD Serono, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| TerSera Therapeutics LLC | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Geron Corporation | 1 | $24 |
| Exelixis Inc. | 1 | $20 |
Products named: VENCLEXTA, Enhertu, DARZALEX, LUTATHERA, DATROWAY, Zoladex, ICLUSIG, RYTELO.
Industry payments across MO — which companies pay providers there.
